Summary of Study ST002256
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001443. The data can be accessed directly via it's Project DOI: 10.21228/M86H66 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST002256 |
Study Title | Metabolomics and metagenomics of pediatric obesity (Serum) |
Study Summary | Pediatric obesity has grown as important global health problem in the world. The pediatric obesity affects all the organs and it is closely linked to risks of metabolic diseases such as diabetes, cardiovascular disease, and mental disease. However, the mechanism of both the pediatric obesity and treatment of the obesity remains unclear. Therefore, we investigated metabolomic pathways related to the pediatric obesity and the treatment through metabolomics and metagenomics approaches. |
Institute | Seoul National University College of Medicine and Hospital |
Last Name | Lee |
First Name | Yujin |
Address | 101, Daehak-ro, Jongno-gu, Seoul, Republic of Korea |
yoojinlee@snu.ac.kr | |
Phone | +821033804686 |
Submit Date | 2022-06-27 |
Raw Data Available | Yes |
Raw Data File Type(s) | smp |
Analysis Type Detail | GC-MS |
Release Date | 2023-01-04 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001443 |
Project DOI: | doi: 10.21228/M86H66 |
Project Title: | Mechanistic study of pediatric obesity through metabolomics and metagenomics |
Project Summary: | Pediatric obesity has grown as an important global health problem in the world. Pediatric obesity affects all the organs and it is closely linked to risks of metabolic diseases such as diabetes, cardiovascular disease, and mental disease. Although many researchers reported results about the pediatric obesity study, the mechanism of both pediatric obesity and its treatment remains unclear. Therefore, we investigated the metabolomic pathways related to pediatric obesity and the treatment through metabolomics and metagenomics approaches. |
Institute: | Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital |
Last Name: | Lee |
First Name: | Yujin |
Address: | 101 Daehak-ro, Jongno-gu, Seoul 110-799, Korea, Seoul, Seoul, 03080, Korea, South |
Email: | yoojinlee@snu.ac.kr |
Phone: | +82-10-3380-4686 |
Subject:
Subject ID: | SU002342 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Gender: | Male and female |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Gender | Group |
---|---|---|---|
SA217107 | N14 | F | Normal |
SA217108 | N10 | F | Normal |
SA217109 | N15 | F | Normal |
SA217110 | N16 | F | Normal |
SA217111 | N22 | F | Normal |
SA217112 | N08 | F | Normal |
SA217113 | N12 | F | Normal |
SA217114 | N05 | F | Normal |
SA217115 | N03 | F | Normal |
SA217116 | M07 | F | Obe |
SA217117 | M14 | F | Obe |
SA217118 | M11 | F | Obe |
SA217119 | M10 | F | Obe |
SA217120 | M16 | F | Obe |
SA217121 | M09 | F | Obe |
SA217122 | M41 | F | Obe |
SA217123 | M25 | F | Obe |
SA217124 | M31 | F | Obe |
SA217125 | M06 | F | Obe |
SA217126 | M19 | F | Obe |
SA217127 | M32 | F | Obe |
SA217128 | M29 | F | Obe |
SA217129 | M08 | F | Obe |
SA217130 | M02 | F | Obe |
SA217131 | N17 | M | Normal |
SA217132 | N09 | M | Normal |
SA217133 | N07 | M | Normal |
SA217134 | N18 | M | Normal |
SA217135 | N06 | M | Normal |
SA217136 | N13 | M | Normal |
SA217137 | N19 | M | Normal |
SA217138 | N11 | M | Normal |
SA217139 | N02 | M | Normal |
SA217140 | N01 | M | Normal |
SA217141 | N04 | M | Normal |
SA217142 | N20 | M | Normal |
SA217143 | M33 | M | Obe |
SA217144 | M28 | M | Obe |
SA217145 | M37 | M | Obe |
SA217146 | M42 | M | Obe |
SA217147 | M40 | M | Obe |
SA217148 | M26 | M | Obe |
SA217149 | M36 | M | Obe |
SA217150 | M35 | M | Obe |
SA217151 | M21 | M | Obe |
SA217152 | M12 | M | Obe |
SA217153 | M15 | M | Obe |
SA217154 | M01 | M | Obe |
SA217155 | M03 | M | Obe |
SA217156 | M05 | M | Obe |
SA217157 | M17 | M | Obe |
SA217158 | M18 | M | Obe |
SA217159 | M23 | M | Obe |
SA217160 | M22 | M | Obe |
SA217161 | M04 | M | Obe |
SA217162 | M20 | M | Obe |
SA217163 | M24 | M | Obe |
Showing results 1 to 57 of 57 |
Collection:
Collection ID: | CO002335 |
Collection Summary: | This longitudinal cohort study is an analysis of serum samples collected from obese children before and after a 2-month weight reduction program that consisted of three visits to the hospital. |
Sample Type: | Blood (serum) |
Treatment:
Treatment ID: | TR002354 |
Treatment Summary: | Participants completed the questionnaires on general lifestyle (the time spent studying and using electronic devices, the duration and frequency of regular exercise, the presence of easily accessible locations to exercise, and their mode of transportation to school) and eating habits (meal duration, the consumption of late-night snacks, the consumption of breakfast, and the intake of sugar-sweetened beverages) and submitted them at the first hospital visit. |
Sample Preparation:
Sampleprep ID: | SP002348 |
Sampleprep Summary: | Frozen serum samples were thawed on ice. For preparation of the serum, a 50 µL sample was extracted using 1 mL of N2-degassed 1st extraction solution. Then, the samples were mixed for 10 min and centrifuged for 10 min at 18945 RCF and 4°C. The supernatant was dried for 6 hours at 45°C. The dried samples were re-extracted with 2nd extraction solution. Then, the extracted samples were redried for 8 hours under the same conditions used in the first extraction step. The dried samples were derivatized with methoxyamine at 30°C for 90 min and subsequently trimethylsilylated with a mixture of fatty acid methyl ester, which is used for the retention time index, in N-methyl-N-(trimethylsilyl)-trifluoroacetamide at 70°C for 45 min. |
Combined analysis:
Analysis ID | AN003685 |
---|---|
Analysis type | MS |
Chromatography type | GC |
Chromatography system | Agilent 7890B |
Column | Restek Rtx-5Sil (30m x 0.25mm,0.25um) |
MS Type | EI |
MS instrument type | GC-TOF |
MS instrument name | Leco Pegasus HT TOF |
Ion Mode | NEGATIVE |
Units | intensity |
Chromatography:
Chromatography ID: | CH002732 |
Instrument Name: | Agilent 7890B |
Column Name: | Restek Rtx-5Sil (30m x 0.25mm,0.25um) |
Chromatography Type: | GC |
MS:
MS ID: | MS003436 |
Analysis ID: | AN003685 |
Instrument Name: | Leco Pegasus HT TOF |
Instrument Type: | GC-TOF |
MS Type: | EI |
MS Comments: | The LECO Corporation ChromaTOF®-GC software (v4.72) was used for data acquisition and extraction. This included computation of baseline (offset of 1; above the noise) and automatic entering the number of data points for smoothing. The software's Statistical Compare was used to align peaks. The MS spectral matching was performed using the NIST and Wiley9 libraries. Also, retention index method was used for identification. |
Ion Mode: | NEGATIVE |